ATE336891T1 - Pharmazeutisches freigabekonstrukt zur magenretention - Google Patents

Pharmazeutisches freigabekonstrukt zur magenretention

Info

Publication number
ATE336891T1
ATE336891T1 AT02725786T AT02725786T ATE336891T1 AT E336891 T1 ATE336891 T1 AT E336891T1 AT 02725786 T AT02725786 T AT 02725786T AT 02725786 T AT02725786 T AT 02725786T AT E336891 T1 ATE336891 T1 AT E336891T1
Authority
AT
Austria
Prior art keywords
construct
gastric retention
pharmaceutical release
region
release construct
Prior art date
Application number
AT02725786T
Other languages
English (en)
Inventor
Jose Gutierrez-Rocca
Josephine Dunne
Matthew Lally
Original Assignee
Kos Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kos Life Sciences Inc filed Critical Kos Life Sciences Inc
Application granted granted Critical
Publication of ATE336891T1 publication Critical patent/ATE336891T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02725786T 2001-04-23 2002-04-23 Pharmazeutisches freigabekonstrukt zur magenretention ATE336891T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28571701P 2001-04-23 2001-04-23
US10/126,828 US20030008007A1 (en) 2001-04-23 2002-04-19 Release pharmaceutical construct for gastric retention

Publications (1)

Publication Number Publication Date
ATE336891T1 true ATE336891T1 (de) 2006-09-15

Family

ID=26825070

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02725786T ATE336891T1 (de) 2001-04-23 2002-04-23 Pharmazeutisches freigabekonstrukt zur magenretention

Country Status (10)

Country Link
US (1) US20030008007A1 (de)
EP (1) EP1383375B1 (de)
JP (1) JP2004528327A (de)
AT (1) ATE336891T1 (de)
AU (1) AU2002256333B2 (de)
CA (1) CA2444601A1 (de)
DE (1) DE60214154T2 (de)
ES (1) ES2266489T3 (de)
MX (1) MXPA03009661A (de)
WO (1) WO2002085112A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
WO2008127287A2 (en) 2006-10-11 2008-10-23 Biolife, L.L.C. Materials and methods for wound treatment
WO2008151041A2 (en) * 2007-05-31 2008-12-11 Biolife, Llc Materials and methods for preparation of alkaline earth ferrates from alkaline earth oxides, peroxides, and nitrates
EP2210585A1 (de) 2009-01-16 2010-07-28 Exelgyn Pharmazeutische SPRM-Zusammensetzungen, Behandlungsverfahren unter Anwendung dieser
EP2408828A4 (de) * 2009-03-19 2013-10-09 Agency Science Tech & Res Bildung von copolymer aus bikontinuierlicher mikroemulsion, die monomere verschiedener hydrophilie umfasst
US9617230B2 (en) 2014-12-22 2017-04-11 Farmington Pharma Development Creatine prodrugs, compositions and methods of use thereof
IL274701B2 (en) 2017-12-01 2024-07-01 Ultragenyx Pharmaceutical Inc Promote drugs, compositions and methods of their use
PT4037666T (pt) 2020-12-08 2024-06-25 Ruminant Biotech Corp Ltd Aperfeiçoamentos de dispositivos e métodos para administração de substâncias a animais

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4085168A (en) * 1971-02-22 1978-04-18 Cpc International Inc. Chemically joined, phase separated self-cured hydrophilic thermoplastic graft copolymers and their preparation
US4851232A (en) * 1987-02-13 1989-07-25 Alza Corporation Drug delivery system with means for obtaining desirable in vivo release rate pattern
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5674242A (en) * 1995-06-06 1997-10-07 Quanam Medical Corporation Endoprosthetic device with therapeutic compound
US6271278B1 (en) * 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
DE69902229T2 (de) * 1998-05-13 2003-02-20 Cygnus, Inc. Sammelvorrichtungen für transdermale probennahmesysteme

Also Published As

Publication number Publication date
DE60214154T2 (de) 2007-07-12
EP1383375B1 (de) 2006-08-23
MXPA03009661A (es) 2005-04-29
AU2002256333B2 (en) 2005-04-14
EP1383375A1 (de) 2004-01-28
DE60214154D1 (de) 2006-10-05
ES2266489T3 (es) 2007-03-01
WO2002085112A1 (en) 2002-10-31
CA2444601A1 (en) 2002-10-31
JP2004528327A (ja) 2004-09-16
EP1383375A4 (de) 2005-03-30
US20030008007A1 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
PT1193270E (pt) Pirrolobenzodiazepinas
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
BR0207640A (pt) Composição farmacêutica oral de cefpodoxima proxetil
MY127290A (en) New use of flibanserin
BR0211972A (pt) Composição oftálmica
DE60041761D1 (de) Tribonektine
AU2002218311A1 (en) Farnesyl protein transferase inhibitors for the treatment of inflammatory bowel disease
BR0306905A (pt) Vacinas de flavivìrus
BR0110383A (pt) Peptìdeo modulador de receptor de trombopoietina
JO2390B1 (en) Diphenylcarboxamides act as lipid-lowering agents
IS7097A (is) Lyfjablanda til að gefa fúlvestrant í vöðva
EP1568691A4 (de) Beschleuniger für die erythropoetinproduktion
HN2001000278A (es) Procedimiento para la preparacion de imidazotriazininas substituidas con sulfonamida.
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
DE60214154D1 (de) Pharmazeutisches freigabekonstrukt zur magenretention
DE60128100D1 (de) Analgetisches arzneimittel
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
BR0203501A (pt) Formulações de multipartìculas biomoduladas
ATE362150T1 (de) Pyramidenfilter
NZ527230A (en) Crystal form of a cyclic depsipeptide having improved activity
BR0112690A (pt) Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos
BR0213463A (pt) Composições farmacêuticas contendo macrólidos
DK1399141T3 (da) Anvendelse af acetyl L-carnitin til fremstilling af et lægemiddel til forebyggende terapi af post-kirurgisk smerte

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1383375

Country of ref document: EP

REN Ceased due to non-payment of the annual fee